GLP-1-Class Drugs Tied to Rare Smell and Taste Problems

“Most patients taking these medications will never experience these symptoms,” Dr. Paunel Vukasinov, dual-board-certified internist and obesity medicine specialist in Manhattan who was not involved in the study, told The Epoch Times.

For patients who remain concerned or develop symptoms, he noted that alternative therapies include SGLT2 inhibitors for diabetes and other FDA-approved anti-obesity medications selected according to the patient’s medical history, treatment goals, and comorbidities. “The choice should always be individualized,” Vukasinov noted. Read the full article.

Would you like to book an appointment with Dr. Vukasinov?